E. Martina Bebin
About
In The Last Decade
E. Martina Bebin
49 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Physiology 922
- Psychiatry and Mental health 810
- Pharmacology 652
- Cellular and Molecular Neuroscience 521
- Molecular Biology 487
Countries citing papers authored by E. Martina Bebin
This map shows the geographic impact of E. Martina Bebin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Martina Bebin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Martina Bebin more than expected).
Fields of papers citing papers by E. Martina Bebin
This network shows the impact of papers produced by E. Martina Bebin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Martina Bebin. The network helps show where E. Martina Bebin may publish in the future.
Co-authorship network of co-authors of E. Martina Bebin
This figure shows the co-authorship network connecting the top 25 collaborators of E. Martina Bebin. A scholar is included among the top collaborators of E. Martina Bebin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Martina Bebin. E. Martina Bebin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 7 | |
| 4 | 3 | |
| 5 | 8 | |
| 6 | 56 | |
| 7 | 5 | |
| 8 | 11 | |
| 9 | 15 | |
| 10 | 158 | |
| 11 | 136 | |
| 12 | 19 | |
| 13 | 28 | |
| 14 | 29 | |
| 15 | 1 | |
| 16 | 101 | |
| 17 | Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial breakdown → | 578 |
| 18 | 2 | |
| 19 | 122 | |
| 20 | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.